- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
S. aureus infection increases risk of atopic dermatitis in infants
Japan: Cheek skin colonized by Staphylococcus aureus is associated with the early development of developing atopic dermatitis in infants, according to a recent study in the Science Translational Medicine. However, despite the presence of bacteria on the skin, infants harboring S. aureus with acquired spontaneous mutations in Agr were more likely to remain healthy. The findings suggest that S. aureus and associated functional quorum sensing may play a role in AD onset in children (Inhibition of Staphylococcus aureus Agr–mediated quorum sensing is known to protect against AD).
Atopic dermatitis is commonly associated with colonization by Staphylococcus aureus in the affected skin. Yuumi Nakamura, Chiba University Graduate School of Medicine, Chiba, Japan, and colleagues performed whole-genome sequencing of S. aureus strains isolated from the cheek skin of 268 Japanese infants 1 and 6 months after birth, to understand the role of S. aureus in the AD development.
Read Also: Atopic Dermatitis: Dupilumab gets FDA approval for pediatric patients
Key findings of the study include:
- About 45% of infants were colonized with S. aureus at 1 month regardless of AD outcome.
- Skin colonization by S. aureus at 6 months of age increased the risk of developing AD.
- Acquisition of dysfunctional mutations in the S. aureus Agr quorum-sensing (QS) system was primarily observed in strains from 6-month-old infants who did not develop AD.
- Expression of a functional Agr system in S. aureus was required for epidermal colonization and the induction of AD-like inflammation in mice
"Thus, retention of functional S. aureus agr virulence during infancy is associated with pathogen skin colonization and the development of AD," concluded the authors.
Read Also: Omega 3 intake by mothers may not benefit brain development of preterm infants
The study, "Staphylococcus Agr virulence is critical for epidermal colonization and associates with atopic dermatitis development," is published in the journal Science Translational Medicine.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751